Cefepime Hcl & Sulbactam For Inj. 1.5gm/3gm Cephalosporins (Dry Powder Injection) Vial

What is Cefepime Hcl & Sulbactam For Inj. 1.5gm/3gm Cephalosporins (Dry Powder Injection) Vial?

Cefepime HCl and Sulbactam for Injection is a combination antibacterial product presented as a dry powder injection. Cefepime is a fourth-generation cephalosporin antibiotic, while sulbactam is a beta-lactamase inhibitor that may help protect susceptible beta-lactam antibiotics from certain bacterial enzymes. The product’s precise indications depend on its approved composition, prescribing information and local regulatory requirements.

Uses / Indications

The combination of cefepime and sulbactam may be used for selected bacterial infections when supported by the approved product information and susceptibility data.

Potential clinical considerations include:

• Selected bacterial infections caused by susceptible organisms.

• Infections involving bacteria that produce certain beta-lactamase enzymes, where the combination’s activity is established.

• Serious infections requiring injectable antibacterial treatment when the combination is clinically appropriate.

The exact indications and antibacterial coverage must be confirmed against the specific product’s approved prescribing information. The supplied information does not establish the precise approved indications for this formulation. It is not intended for viral infections such as influenza or the common cold.

6. Benefits

• Combines cefepime, a cephalosporin antibiotic, with sulbactam, a beta-lactamase inhibitor.

• Presented as a dry powder injection for preparation according to approved instructions.

• May provide a useful antibacterial option for selected infections when supported by susceptibility and prescribing information.

• Intended for use in appropriate clinical settings under professional supervision.

• Kelar Pharmachem India supports pharmaceutical sourcing and export requirements, subject to product availability and destination-market requirements.

Clinical suitability depends on the specific formulation, causative organism, susceptibility profile and patient characteristics.

7. Side Effects

The potential adverse effects depend on the individual ingredients, their doses and the specific approved formulation.

Common Side Effects

Potential effects associated with cefepime-containing treatment may include:

• Diarrhoea.

• Nausea or vomiting.

• Skin rash.

• Injection-site reactions.

• Headache.

The frequency of these effects for the specific combination has not been established from the information supplied.

Less Common or Serious Side Effects

• Serious allergic reactions, including anaphylaxis.

• Severe or persistent antibiotic-associated diarrhoea, including possible Clostridioides difficile infection.

• Changes in blood cell counts or liver function tests.

• Kidney-related complications in susceptible patients.

• Neurological toxicity, including confusion, altered consciousness, myoclonus or seizures, particularly when cefepime accumulates in patients with renal impairment.

Sulbactam may have additional adverse effects depending on the formulation. Consult the approved product information for the complete safety profile. Suspected serious reactions require prompt medical assessment.

8. How Does It Work?

Cefepime acts by binding to bacterial penicillin-binding proteins and interfering with bacterial cell-wall synthesis. This can cause the death of susceptible bacteria.

Sulbactam inhibits certain beta-lactamase enzymes produced by bacteria. These enzymes can inactivate some beta-lactam antibiotics. By inhibiting susceptible enzymes, sulbactam may help protect the accompanying antibiotic against those mechanisms of resistance.

The combination does not overcome every form of bacterial resistance, and its effectiveness depends on the organisms involved and their susceptibility to the formulation.

9. Dosage Guidelines

Dosage depends on the verified composition and strength, infection being treated, infection severity, patient age and weight where relevant, renal function, and the approved prescribing information.

• Confirm the exact amount of each active ingredient represented by the stated 1.5gm/3gm presentation.

• Do not infer the individual ingredient strengths from the product name alone.

• Dosage adjustment may be required in patients with renal impairment.

• Reconstitution, dilution and administration must follow the approved instructions for this exact formulation.

• Preparation and administration must be performed by appropriately qualified healthcare professionals.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

10. When Not to Use

The combination should not be used in patients with a known serious hypersensitivity to its active ingredients or any other component for which the approved product information specifies a contraindication.

Before administration:

• Review previous reactions to cefepime and other cephalosporins.

• Assess any history of serious allergy to penicillins or other beta-lactam antibiotics.

• Consider renal function and relevant patient-specific risks.

• Check all contraindications listed in the approved product documentation.

A penicillin allergy does not automatically contraindicate every cephalosporin. Allergy history and possible cross-reactivity should be assessed by a qualified healthcare professional.

11. Drug / Product Interactions

Potential interactions should be reviewed using the approved prescribing information for the combination.

Relevant considerations may include:

• Aminoglycosides: Concurrent treatment may warrant renal-function monitoring.

• Medicines affecting renal function: Assess potential effects on drug clearance and toxicity risk.

• Anticoagulants: Monitoring may be appropriate where the specific medicine and clinical circumstances indicate a potential interaction.

• Other antibiotics: Combination treatment should be based on clinical need and applicable treatment guidance.

These are considerations for clinical review, not a claim that every interaction applies to this formulation. Healthcare professionals should check the full interaction information before use.

12. Safety Advice

• Use only under appropriate medical supervision.

• Verify the exact composition and strength before administration.

• Check the patient’s allergy history.

• Assess renal function and adjust treatment when required by the approved information.

• Follow product-specific preparation, compatibility and administration instructions.

• Monitor for allergic reactions, severe diarrhoea and neurological changes as clinically appropriate.

• Use antibiotics only for suitable bacterial indications and follow antimicrobial stewardship principles.

Pregnancy, breastfeeding and paediatric use should be assessed according to the approved product information and the patient’s clinical circumstances.

13. General Instructions

• Check the product name, active ingredients, strength, batch number and expiry date.

• Inspect the vial and container closure for damage.

• Follow the approved instructions for reconstitution and administration.

• Maintain appropriate aseptic handling practices.

• Do not use damaged containers or products that fail applicable quality checks.

• Confirm compatibility before mixing with other medicines.

• Follow product-specific instructions for use and storage after reconstitution.

• Dispose of unused medicine and clinical waste in accordance with applicable procedures.

Do not assume a universal diluent, preparation volume, administration method or post-reconstitution stability period.

14. Special Dietary / Lifestyle Tips

No universal dietary restriction can be established for this injectable combination from the information supplied.

• Follow the treatment plan provided by the healthcare professional.

• Complete treatment according to the prescribed instructions.

• Do not share antibiotics with others.

• Report persistent diarrhoea, rash, confusion or other concerning symptoms promptly.

• Follow individual fluid-intake advice where renal disease or another condition requires restrictions.

Dietary and lifestyle guidance should be based on the patient’s overall medical condition and any additional treatment requirements.

15. Comparison with Other Treatments

Cefepime and sulbactam combine a cephalosporin antibiotic with a beta-lactamase inhibitor. The clinical role of this combination depends on the specific formulation and its documented antibacterial activity.

The combination should not be assumed to be more effective than other antibiotics in all situations. Antibiotic selection depends on the pathogen, susceptibility results, infection site, patient factors and local treatment guidance.

16. Precautions & Warnings

• Hypersensitivity: Review previous reactions to cephalosporins, penicillins and other beta-lactam antibiotics.

• Renal impairment: Renal-function assessment and dose adjustment may be necessary.

• Neurological effects: Cefepime-associated neurological toxicity is an important consideration, particularly in patients with impaired renal function.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires medical evaluation.

• Laboratory monitoring: Blood counts, renal function or liver function may require monitoring according to the patient’s condition and product information.

• Antimicrobial resistance: Use only when clinically indicated and according to appropriate antibiotic guidance.

• Special populations: Pregnancy, breastfeeding and paediatric use require assessment against the approved product information.

The full warnings for the exact combination must be verified before publication.

17. Can I Use It With Other Medicines?

Concomitant use depends on the exact formulation, the patient’s medical condition and the other medicines being taken.

Inform the healthcare professional about:

• All prescription and non-prescription medicines.

• Other antibiotics.

• Aminoglycosides and medicines that may affect renal function.

• Anticoagulants and other medicines requiring monitoring.

• Vitamins and supplements.

Physical compatibility is separate from systemic drug interactions. Do not mix this product with other medicines in a syringe, infusion container or administration line unless compatibility has been confirmed in the approved instructions.

18. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Storage requirements before reconstitution may differ from those after preparation. Temperature limits, protection requirements and the permitted period of use after reconstitution must be confirmed from the documentation for this exact formulation.

19. Frequently Asked Questions (FAQs)

1. What is Cefepime HCl and Sulbactam Injection used for?

It is a combination antibacterial product intended for selected bacterial infections when supported by the approved prescribing information. The exact indications must be confirmed for this formulation.

2. Which active ingredients does this product contain?

The supplied product name identifies cefepime HCl and sulbactam. The individual ingredient quantities should be verified from the approved product specification.

3. What do the stated strengths of 1.5gm/3gm mean?

The supplied listing states 1.5gm/3gm, but it does not clarify the individual ingredient quantities or whether these refer to separate presentations. Confirm the exact strength configuration before publication.

4. How is this dry powder injection prepared?

A qualified healthcare professional must prepare the product according to its approved instructions. The diluent, preparation volume and administration method should not be assumed.

5. Can patients with a penicillin allergy receive this combination?

Not without an appropriate allergy assessment. A healthcare professional must review the previous reaction, potential cross-reactivity and product-specific contraindications.

6. What precautions are important during treatment?

Important considerations include allergy history, renal function, appropriate dosage, neurological symptoms and severe or persistent diarrhoea.

7. How should the product be stored?

Follow the manufacturer’s approved labelling. The storage conditions before and after reconstitution must be confirmed from the product-specific documentation.

8. Is this product available for pharmaceutical export?

Kelar Pharmachem India is a pharmaceutical sourcing and export company. Product availability, packing, documentation and destination-market requirements should be confirmed with the company.

This information is intended for pharmaceutical product reference and does not replace approved prescribing information or professional medical advice.